LONDON (AFX) - Syntopix Group PLC said it is to put three potential acne treatments into clinical product development.
Syntopix -- a drug company spun off from the University of Leeds -- said it has made patent applications for the three compounds, which combat acne and staphylococcal infections.
All three compounds have a history of use in man, in line with the company's reduced-risk strategy, it said.
